Compile Data Set for Download or QSAR
Report error Found 53 Enz. Inhib. hit(s) with all data for entry = 50011521
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490068(US10968172, ID # 19y | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 20nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490051(US10968172, ID # 19g | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 20nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490037(US10968172, ID # 14c | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 20nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490029(US10968172, ID # 10e | (S)-N-(1-((4-(tert- butyl)s...)
Affinity DataIC50: 20nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490045(US10968172, ID # 19a | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 30nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490042(US10968172, ID # 14h | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 30nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489719(US10968172, ID # 4j | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 49nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490041(US10968172, ID # 14g | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 60nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490026(US10968172, ID # 10b | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 60nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490036(US10968172, ID # 14b | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 80nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490016(US10968172, ID # 7f | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 90nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM445169(US10669234, Example 126 | (S)-1-cyano-N-(4-(3- cya...)
Affinity DataIC50: 100nMAssay Description:Inhibition of USP30 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489727(US10968172, ID # 4n | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 100nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490044(US10968172, ID # 14j | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 120nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489704(US10968172, ID # 4c | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 120nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489745(US10968172, ID # 4x | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 160nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489738(US10968172, ID # 4q | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 180nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490035(US10968172, ID # 14a | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 230nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490032(US10968172, ID # 10h | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 250nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489702(US10968172, ID # 4a | (R)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 250nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489703(US10968172, ID # 4b | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 270nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489739(US10968172, ID # 4r | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 270nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548233(CHEMBL4756029)
Affinity DataIC50: 370nMAssay Description:Inhibition of USP30 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489721(US10968172, ID # 4l | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 370nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490040(US10968172, ID # 14f | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 460nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490012(US10968172, ID # 7b | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 470nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548239(CHEMBL4747607)
Affinity DataIC50: 510nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490013(US10968172, ID # 7c | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 670nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489709(US10968172, ID # 4g | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 830nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490017(US10968172, ID # 7g | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 2.27E+3nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489715(US10968172, ID # 4i | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489730(US10968172, ID # 4p | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 4.30E+3nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489743(US10968172, ID # 4v | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 9.00E+3nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetProbable ubiquitin carboxyl-terminal hydrolase FAF-X(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548233(CHEMBL4756029)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 8(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548233(CHEMBL4756029)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP8 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548234(CHEMBL4745470)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548233(CHEMBL4756029)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548235(CHEMBL4793428)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548236(CHEMBL4790811)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489705(US10968172, ID # 4d | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM490025(US10968172, ID # 10a | (S)-N-(1-((4-(N-(tert- buty...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548237(CHEMBL4758731)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548238(CHEMBL4788134)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489707(US10968172, ID # 4e | (S)-N-(5-(N-(tert- butyl)sul...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548245(CHEMBL4752106)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489708(US10968172, ID # 4f | (S)-N-(5-(N-(tert- butyl)sul...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM489744(US10968172, ID # 4w | (S)-N-(1-((5-(N-(tert- butyl...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548244(CHEMBL4786750)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548243(CHEMBL4784815)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mitobridge, Inc. (An Astellas)

Curated by ChEMBL
LigandPNGBDBM50548242(CHEMBL4754174)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
Displayed 1 to 50 (of 53 total ) | Next | Last >>
Jump to: